AtriCure, Inc.

NASDAQ:ATRC

Medical - Instruments & Supplies

Healthcare
$55.45 +3.52%

+$0.96 today

Market cap
$2.82B
Beta
1.26
P/E (TTM)
-295.5
EPS (TTM)
-$0.10
52W Low $25.36High $43.18

Volume 0.60M

Average 0.77M

ATRC Investing Cash Flow

Net cash used in or generated by investments in assets, acquisitions, and securities.

AtriCure, Inc.NASDAQ: ATRC

Investing Cash Flow · Q2 FY2026 · quarter ended Jun 2026

Investing cash flow declines year over year

Q2 FY2026 investing cash flow of $3.77M (cash outflow) fell 50.8% year over year, behind the -34.7% change in trailing-twelve-month investing cash flow. Sequentially, it fell 2.2% from the prior quarter.

Context

  • Investing cash flow amounted to 2.7% of revenue in FY2025, down 3.8 pp from a year earlier.
  • Investing cash flow increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -50.8% toward the trailing-twelve-month pace of -34.7%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJun 2026
-$3.77M-2.2% QoQ
Last fiscal yearDec 2025
-$14.55M-148.1% YoY
LTMJun 2026
-$12.83M-34.7% YoY
Investing Cash Flow past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-50.8%——
1 year-148.1%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Investing Cash Flow history

USD · from the cash flow

Latest · FY2025
(14.55M) USD
Year-over-year change
-148.1%

Investing Cash Flow vs competitors

How ATRC compares with its peers on the latest reported figures

  • ATRC's LTM Jun 2026 investing cash flow of $12.83M is the smallest of the 5 companies compared; the peer median is $2.24B.
  • Its year-over-year change of -34.7% is the 3rd highest of 5, against a peer median of +6.3%.
  • Investing cash flow amounts to 2.3% of revenue for ATRC, versus a peer median of 12.1%.
ATRC Competitors Peer median
Investing Cash Flow for ATRC and competitors
Company Period LTM YoY 3-year CAGR% of revenue
MDTMedtronic plcLTM Jul 2026$3.83B +59.9%-5.6%10.2%
BSXBoston Scientific CorporationLTM Jun 2026$3.56B -47.3%+9.5%17.0%
EWEdwards Lifesciences CorporationLTM Jun 2026$912.1M -144.8%—14.0%
LIVNLivaNova PLCLTM Sep 2026$99.76M +86.9%+23.8%6.6%
ATRCAtriCure, Inc.LTM Jun 2026$12.83M -34.7%—2.3%
Peer median (excluding ATRC) $2.24B+6.3%+9.5%12.1%

Competitors are the stored peer set for ATRC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income50.2M(46.47M)(30.44M)(44.7M)(11.45M)
Depreciation & Amortization10.44M11.71M14.81M18.73M20.53M
Deferred Income Tax84.78M0000
Stock-Based Compensation28.08M28.77M35.73M40.41M44.69M
Change in Working Capital(4.85M)(18.88M)(18.24M)(18.36M)(4.29M)
Accounts Receivables(10.09M)(8.99M)(9.87M)(8.3M)(5.61M)
Inventory(4.27M)(7.31M)(21.83M)(7.74M)(2.26M)
Accounts Payables4.71M2.68M6.18M(1.53M)(960K)
Other Working Capital4.81M(5.26M)7.29M(786K)4.54M
Other Non-Cash Items(182.43M)2.72M2.62M16.12M7.85M
Operating Cash Flow(13.78M)(22.14M)4.48M12.2M57.33M
Capital Expenditures(9.75M)(16.88M)(42M)(23.46M)(9.05M)
Acquisitions (Net)(33.26M)(44.01M)000
Purchases of Investments(173.11M)(24.64M)000
Sales of Investments206.36M85.52M63.82M00
Other Investing Activities33.26M44.01M(30M)41.69M(5.5M)
Investing Cash Flow23.5M44.01M21.82M30.23M(14.55M)
Debt Repayment(816K)(899K)(992K)(1.67M)5.05M
Common Stock Issued00007.29M
Common Stock Repurchased(18.01M)(12.2M)(6.56M)(6.95M)(11.16M)
Dividends Paid00000
Other Financing Activities11.19M6.04M7.52M5.02M0
Financing Cash Flow(7.64M)(7.06M)(32K)(3.6M)1.18M
Effect of Forex Changes(372K)(361K)(58K)(424K)747K
Net Change in Cash1.71M14.45M26.21M38.41M44.71M
Free Cash Flow(23.53M)(39.02M)(37.51M)(11.26M)48.28M

AtriCure, Inc.

NASDAQ:ATRC

Intrinsic Alpha fair value

Locked

Current Price

$55.45

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.